Skip to content

PRME - Prime Medicine, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchP

Prime Medicine, Inc. Common Stock

PRME · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

P

PRMEPrime Medicine, Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $6.94
52-wk low: $2.67
Prev close: $4.92
Mkt cap: $642.1M
Beta: 2.31
P/S: 157.6x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$133.1M

CW
Cathie Wood
Q2 2026 13F
$30.8M
position
BA
Balyasny
Dmitry Balyasny · Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings landed in line with what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $642M

Valuation

P/S157.64
P/B0.28

Quality

Operating margin-3751.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: PRME
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $642.07M
Beta: 2.31

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

0.3x

Profit margin

+0.0%

Op margin

-3751.0%

ROE

-373.3%

$14.6M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$7.6M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for PRME

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.24+0.0%

-$0.24 expected

Next report

What the street expects next

-373.3%

ROA-46.5%

Growth

Beta2.31